Filing Flows › Kestra Medical Technologies (KMTS) › Q1 FY26
Kestra Medical Technologies (KMTS) Q1 FY26 earnings results (first quarter fiscal 2026)
10-Q filed Sep 12, 2025
Kestra Medical Technologies (KMTS) reported revenue of $19.4M for the first quarter fiscal 2026 (Q1 FY26), +52% from a year earlier and +12% from the quarter before. Operating margin was -149.1%, net loss $25.8M (133.3% of revenue).
Kestra Medical Technologies, Q1 FY26: revenue $19.4M (+52% year over year), operating margin -149.1%, net loss $25.8M, operating cash flow −$26.3M. The chart follows the revenue to costs, profit and cash.
| Q1 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $19.4M | +12% | +52% |
| Operating profit | −$28.9M | — | — |
| Net earnings | −$25.8M | — | — |
| Operating cash flow | −$26.3M | — | — |
What changed
Revenue was $19.4M in Q1 FY26, up 52% year over year and up 12% from the previous quarter.
Gross margin was 45.7%, up 12.8 points from a year earlier. Operating costs exceeded revenue by $28.9M, an operating margin of -149.1%. Operating expenses grew 67% against revenue growth of 52%. The fastest-growing cost line was SG&A (+75%). The quarter ended with a net loss of $25.8M, narrower than the previous quarter's $51.1M loss.
Operating cash flow was −$26.3M. Non-cash charges added back $2.0M of depreciation and $4.6M of share-based compensation. Working capital and other items used $7.1M. Capital expenditures of $8.2M exceeded it, leaving free cash flow of −$34.4M.
Questions
What was Kestra Medical Technologies' revenue in the first quarter fiscal 2026?
Kestra Medical Technologies (KMTS) reported revenue of $19.4M for the first quarter fiscal 2026 (Q1 FY26), +52% from a year earlier and +12% from the quarter before.
Was Kestra Medical Technologies profitable in the first quarter fiscal 2026?
Operating loss was $28.9M (-149.1% of revenue) and net loss $25.8M.